JP2012520855A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012520855A5 JP2012520855A5 JP2012500269A JP2012500269A JP2012520855A5 JP 2012520855 A5 JP2012520855 A5 JP 2012520855A5 JP 2012500269 A JP2012500269 A JP 2012500269A JP 2012500269 A JP2012500269 A JP 2012500269A JP 2012520855 A5 JP2012520855 A5 JP 2012520855A5
- Authority
- JP
- Japan
- Prior art keywords
- vivo
- contrast agent
- vivo imaging
- pbr
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 13
- 239000002872 contrast media Substances 0.000 claims 10
- 238000001727 in vivo Methods 0.000 claims 10
- 238000011503 in vivo imaging Methods 0.000 claims 10
- 239000002243 precursor Substances 0.000 claims 8
- 239000012216 imaging agent Substances 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 2
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 2
- 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 claims 1
- XNRDLSNSMTUXBV-UHFFFAOYSA-N 2-fluoroethyl 4-methylbenzenesulfonate Chemical compound CC1=CC=C(S(=O)(=O)OCCF)C=C1 XNRDLSNSMTUXBV-UHFFFAOYSA-N 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 239000012217 radiopharmaceutical Substances 0.000 claims 1
- 229940121896 radiopharmaceutical Drugs 0.000 claims 1
- 230000002799 radiopharmaceutical effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 238000011269 treatment regimen Methods 0.000 claims 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16142509P | 2009-03-19 | 2009-03-19 | |
| GB0904715.0 | 2009-03-19 | ||
| US61/161,425 | 2009-03-19 | ||
| GBGB0904715.0A GB0904715D0 (en) | 2009-03-19 | 2009-03-19 | Aryloxyanilide derivataives |
| PCT/EP2010/053614 WO2010106166A2 (en) | 2009-03-19 | 2010-03-19 | Aryloxyanilide derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012520855A JP2012520855A (ja) | 2012-09-10 |
| JP2012520855A5 true JP2012520855A5 (enExample) | 2013-05-02 |
| JP5787873B2 JP5787873B2 (ja) | 2015-09-30 |
Family
ID=40639799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012500269A Expired - Fee Related JP5787873B2 (ja) | 2009-03-19 | 2010-03-19 | インビボイメージング用の放射性標識ピリジニル誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120003154A1 (enExample) |
| EP (1) | EP2408451A2 (enExample) |
| JP (1) | JP5787873B2 (enExample) |
| CN (1) | CN102355899B (enExample) |
| GB (1) | GB0904715D0 (enExample) |
| WO (1) | WO2010106166A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0921967D0 (en) * | 2009-12-17 | 2010-02-03 | Ge Healthcare Ltd | Novel Aryloxyanilide Derivatives |
| KR101602912B1 (ko) * | 2013-09-13 | 2016-03-11 | 주식회사 바이오이미징코리아 | [18f]플루오르메틸기가 도입된 뇌신경염증 표적 양성자방출단층촬영 방사성추적자, 이의 합성 및 그를 이용한 생물학적 결과 평가 방법 |
| CN108430786B (zh) * | 2015-12-28 | 2021-06-15 | 宝洁公司 | 使用在双侧上偏转的转移部件将材料施加到制品上的方法和设备 |
| WO2017192816A1 (en) * | 2016-05-06 | 2017-11-09 | Entrust Datacard Corporation | Label module for printing custom customer engagement labels |
| CN119409686B (zh) * | 2025-01-07 | 2025-09-05 | 四川大学华西医院 | 苯杂氮卓类衍生物、放射性探针及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4302207B2 (ja) * | 1997-08-04 | 2009-07-22 | 大正製薬株式会社 | アリールオキシアニリン誘導体 |
| US6333358B1 (en) * | 1997-08-04 | 2001-12-25 | Taisho Pharmaceutical Co., Ltd. | Aryloxyaniline derivatives |
| JP2000001476A (ja) * | 1998-06-15 | 2000-01-07 | Taisho Pharmaceut Co Ltd | アリールオキシ含窒素アリールアミン誘導体 |
| GB0115927D0 (en) | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase nucleophilic fluorination |
| GB0115929D0 (en) | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase electrophilic fluorination |
| US6870069B2 (en) | 2003-01-10 | 2005-03-22 | National Institute Of Radiological Sciences | Phenyloxyaniline derivatives |
| JPWO2006092902A1 (ja) | 2005-02-28 | 2008-08-07 | 大正製薬株式会社 | 放射性ハロゲン標識フェニルオキシアニリン誘導体 |
| WO2007036785A2 (en) | 2005-09-29 | 2007-04-05 | Ge Healthcare Limited | Carbon-isotope monoxide labeling of daa1106 and its analogues to be used as tracers for a peripheral type benzodiazepine binding site |
| US20090142264A1 (en) | 2005-12-28 | 2009-06-04 | Bengt Langstrom | 18F-Labeled Phenoxyphenyl Nu-benzyl Alkanamid Derivatives for Positron Emission Tomography (PET) Imaging of Peripheral Benzodiazepine Receptor |
| WO2010015340A1 (en) * | 2008-08-06 | 2010-02-11 | Bayer Schering Pharma Aktiengesellschaft | Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
-
2009
- 2009-03-19 GB GBGB0904715.0A patent/GB0904715D0/en not_active Ceased
-
2010
- 2010-03-19 JP JP2012500269A patent/JP5787873B2/ja not_active Expired - Fee Related
- 2010-03-19 US US13/256,678 patent/US20120003154A1/en not_active Abandoned
- 2010-03-19 EP EP10709537A patent/EP2408451A2/en not_active Withdrawn
- 2010-03-19 CN CN201080012633.4A patent/CN102355899B/zh not_active Expired - Fee Related
- 2010-03-19 WO PCT/EP2010/053614 patent/WO2010106166A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012521973A5 (enExample) | ||
| TWI660947B (zh) | 用於合成造影劑及其中間體之方法及裝置 | |
| JP2013047277A5 (enExample) | ||
| ES2554772T3 (es) | Azabenzoxazoles sustituidos novedosos | |
| JP2012520855A5 (enExample) | ||
| JP2013528161A5 (enExample) | ||
| RU2011138850A (ru) | Трициклические индольные производные в качестве лигандов pbr | |
| JP2012504581A5 (enExample) | ||
| RU2505528C2 (ru) | Соединения для применения в визуализации, диагностике и/или лечении заболеваний центральной нервной системы или опухолей | |
| CN108779111B (zh) | 结合脱氧胞苷激酶的化合物 | |
| Hostetler et al. | Evaluation of [18F] MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human | |
| RU2011111787A (ru) | Производные индола, подходящие для визуализации нейровоспаления | |
| JP2010513441A5 (enExample) | ||
| RU2016119524A (ru) | Зонд для визуализации тау белка | |
| Zhang et al. | Synthesis, preclinical evaluation, and first-in-human PET study of quinoline-containing PSMA tracers with decreased renal excretion | |
| JP2007500730A5 (enExample) | ||
| JP2012523388A5 (enExample) | ||
| JP2016530266A (ja) | デオキシシチジンキナーゼ阻害因子 | |
| JP2013507345A5 (enExample) | ||
| Dong et al. | Synthesis Principle and Practice with Radioactive Iodines and Astatine: Advances Made So Far | |
| JP2012523388A (ja) | プリン作動性p2x7受容体結合剤を用いた中枢神経系のイメージング | |
| CN112469701A (zh) | Tspo结合剂 | |
| JP2019507155A5 (enExample) | ||
| JP2011509294A5 (enExample) | ||
| JP6609868B2 (ja) | 放射性ハロゲン標識ピリド[1,2−a]ベンゾイミダゾール誘導体化合物 |